Two-year sustained reversal of type 2 diabetes
A prospective, non-randomized trial showing durable A1C improvement and medication reduction at 24 months.
Read study →Clinical outcomes, reported transparently.
We publish our outcomes in peer-reviewed journals and report real-world data for every book of business. No cherry-picked cohorts, no marketing math.
−1.3ptsA1C reduction at 12 months (members w/ type 2 diabetes)
63%Off at least one diabetes medication
31lbsAverage weight loss sustained at 12 months
5 yrDurable reversal documented in long-term cohort
Peer-reviewed evidence
Outcomes that hold up under scrutiny.
Five-year outcomes & cardiovascular markers
Long-term follow-up data on lipid panel, blood pressure, and ASCVD risk in the reversal cohort.
Read study →Real-world outcomes across a commercial population
Analysis across 12,000+ members spanning employer and health-plan channels.
Read study →
$5,200
Average per-member medical cost savings documented by actuarial partners.
Cost & utilization
Better health outcomes. Lower total cost of care.
Independent actuarial reviews of our book of business consistently show reduced medical claims and pharmacy spend within the first 12 months. Savings compound over years two and three.
See the employer report